Telithromycin-resistant Streptococcus pneumoniae [1]

Emerging Infectious Diseases

Volumn 11, Issue 9, 2005, Pages 1489-1490

  Goldstein, Fred ^a   Vidal, Barbara ^a   Kitzis, Marie D ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMOXICILLIN; C REACTIVE PROTEIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; MIKAMYCIN B; PREDNISOLONE; ROXITHROMYCIN; STREPTOCOCCUS ANTIGEN; TELITHROMYCIN; TERBUTALINE; TETRACYCLINE DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; LETTER; LOBAR PNEUMONIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; RASH; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 23944472110     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1109.050415     Document Type: Letter

References (8)

1. Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian network for surveillance of resistant pathogens (ANSORP). J Antimicrob Chemother. 2004;53:457-63.
2. Leclercq R. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin. J Antimicrob Chemother. 2001;48:9-23.
3. Farrell J, Felmingham D. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003. Antimicrob Agents Chemother. 2004;48:1882-4.
4. Goldstein FW, Dang Van A, Bouanchaud DH, Acar JF. Increased resistance of Streptococcus pneumoniae to antibiotic and prevalence of their capsular serotypes. Pathol Biol. 1978;26:173-80.
5. Goldstein FW. Penicillin-resistant Streptococcus pneumoniae: section by beta-lactam and non-beta-lactam antibiotics. J Antimicrob Chemother. 1999;44:141-4.
6. Lonks JR. What is the clinical impact of macrolide resistance? Current Infect Dis Rep. 2004;6:7-12.
7. Zhanel G, Johanson C, Laing N, Hisanaga T, Wierzbowski A, Hoban DJ. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary. Antimicrob Agents Chemother. 2005;49:1943-8.
8. Batard E, Juvin ME, Jacqueline C, Bugnon D, Caillon J, Potel G, et al. Influence of carbon dioxide on the MIC of telithromycin for Streptococcus pneumoniae: an in vitro-in vivo study. Antimicrob Agents Chemother. 2005;49:464-6.